Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3364929 A
Publication typeGrant
Publication dateJan 23, 1968
Filing dateDec 21, 1964
Priority dateDec 21, 1964
Also published asDE1539104A1, DE1539104B2
Publication numberUS 3364929 A, US 3364929A, US-A-3364929, US3364929 A, US3364929A
InventorsWalter S Ide, William H Nickerson
Original AssigneeBurroughs Wellcome Co
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Method for administering muscle relaxant drug
US 3364929 A
Abstract  available in
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Jan. 23, 1968 w. 5.105 ETAL 3,364,929

- METHOD FOR ADMINISTERING MUSCLE RELXANT DRUG Filed Dec. 2l, 1964 ,zo ,22 3 lll 5? 45 f2( 58 56X z3 40 Z8 2Q 25 E 5M@ 6&5 N

Z5 75 HM' METER 0R A OSCILLOSCOPE ELE CTR \CQL. SUMUU TwlTcH fTETANus TwITH gb Nowoepommzme BLOCK MH @Us TunTcH g" .36. DEPoLQmzmG BLOCK INVBNTORS HHH l I l I I wlham H .NwKevmm Y BY TwlTcH TETANUSl TwmzH 90M@ (mm Y ATTQRNEY` United States Patent Office 3,364,929 Patented Jan. 23, 1968 3,364,929 METHOD FOR ADMINISTERING MUSCLE RELAXANT DRUG Walter S. Ide, Eastchester, and William H. Nickerson,

Tuckahoe, N.Y., assignors to Burroughs Wellcome &

Co. (U.S.A.) Inc., Tucltahoe, N Y., a corporation of New York Filed Dec. 21, 1954, Ser. No. 419,949 4 Claims. (Cl. 128-172.1)

ABSTRACT OF THE DISCLOSURE A method for administering a muscle relaxant antagonist drug to counteract muscle relaxant drugs which produce both non-depolarizing and depolarizing blocks in patients, comprising the steps of rst applying an electrical stimulus to the ulnar nerve and/ or the nerve motor point muscle junction of a patient at a twitching frequency rate, secondly applying electrical stimulus at a tetanus frequency rate to the same part of the patient, and thirdly reapplying the electrical stimulus at the frequency rate, differentiating between responsiveness of the patient to said stimuli to determine the types of neuromuscular block, and introducing an antagonist into the system of the patient only if the response of the patient is such that a non-depolarizing block exists.

Athe completion of surgery, it is sometimes required that the patient who has been administered a muscle relaxant drug be stimulated by the administration of an antagonist drug to counteract the elfects of the muscle relaxant drug. Commonly used antagonist drugs are physostigmine, eserine and edrophonium.

In some instances instead of the antagonist stimulating the patient a continuation of the relaxation of the patient for prolonged periods has occurred. The prolonged period of relaxation has tended to be greater than that which would ordinarily occur without the administration of the antagonist, It is believed that this continuation of relaxation is related to the type of neuromuscular block existing in the patient.

In View of the foregoing, a new and improved apparatus for determining the correct time to administer muscle `antagonist drugs was required. Additionally, a new and improved method was required in order to administer antagonists to produce a stimulation of the patient instead of prolonging the relaxation of the patient. Accordingly, it is an object of this invention to provide a new and improved apparatus for providing electrical stimuli4 to differentiate between depolarizing and nondepolarizing neuromuscular blocks due to the action of certain muscle relaxant drugs.-

Another object of this `invention is to provide a new and improved method of administering antagonist drugs. It is a further object of this invention to provide a new and improved method of determining when to introduce muscle relaxant drugs and the administration of such drugs.

It is'an additional object of this invention to provide a new and improved and simplified monitoring apparatus for stimulating the patient and to determine the type of neuromuscular block exhibited by the patient.

Other objects of the invention will in part be obvious and will in part appear hereinafter.

The invention accordingly comprises the several steps and the relation of one or more of such steps with respect to each of the others, and the apparatus embodying features of construction, combinations of elements and arrangements of parts which are adapted to eect such steps, all as exemplified in the following detailed disclosure, and the scope of the invention will be indicated in the claims.

For a fuller understanding of the nature and objects of the invention, reference should be had to the following detailed description taken in conjunction with the accompanying drawings, in which FIG. 1 illustrates schematically a transistorized, neuromuscular block monitoring device;

FIG. 2 is an isometric representation of a splint for mounting on a patient to detect response of a patient to electrical stimuli;

FIG. 3a is a graph illustrating the sequential electrical stimuli applied to the patient in accordance with this invention;

FIG. 3b is a graph showing the resultant response of a patient to the electrical stimuli as a result of a non-depolarizing block affecting the nerves of the patient; and

FIG 3c is a graph illustrating a depolarizing block of a patient in response to electrical stimuli.

Referring now to FIGS. l and 2, a monitor oscillator or pulse generator is shown at 20 for generating an electrical stimuli in accordance with this invention. The pulse generator Z0 includes a relaxation oscillator circuit having an NPN transistor 21 with an emitter electrode 22, a base electrode 23 and a collector electrode 24 and a PNP transistor 25 with an emitter electrode 26, a base electrode 27 and a collector electrode 28. The collector 24 of transistor 21 is coupled to the base 27 of transistor 25. Connected between the base electrode 23 of transistor 21 and collector electrode of transistor 25 is a capacitor 30. Coupled intermediate the base 23 of transistor 21 and capacitor 30 is a variable resistance network for varying the frequency of the oscillator. The resistance network includes a switch 31 and two resistors 33 and 34, Switch 31 can be connected to either of resistors 33 and 34 to control the frequency of the oscillator. A source of direct current energy 34, such as a battery, is coupled at its positive terminal to emitter 26 of transistor 25 and to the other end of resistors 33 and 34. A switch 36 is provided in the line to place the DC energy source 35 in the circuit, One end of the switch is coupled to the emitter 22 and the other end of the switch is coupled to the battery 35. A voltage step-up transformer is generally shown at 37. Transformer has its primary winding 38 between the collector 28 of transistor 25 and emitter 22 of transistor 21.

A resistor 40 coupled in series with capacitor 30 and a capacitor 41 connected across winding 38 are preferably included to decrease extraneous voltages in the circuit. The secondary winding 39 of transformer 37 is coupled across a resistor 4S and a gas tube 46. The'resistor 45 and gas tube 46 are in parallel with a variable resistor 47. The gas tube 46 indicates when the device 20 is providing a signal of a predetermined voltage level. Coupled across variable resistor 47 is a first electrode 50 and a second electrode 51 connected through a resistor 49. The electrodes may be surface-type electrodes which are suitable for applying an electrical stimuli to the arm 52 of a patient. But, preferably, needle-type electrodes are utilized which may be of the standard 25 gage metal needle type.

The electrodes are placed on the arm or the legs of a patient in a well -known manner such that the ulnar nerve and/or the nerve motor point muscle function is stimulated by the signal provided from the oscillator 20. The oscillator operates as follows: upon closure of switch 36 and the connection of switch 31 to one of resistors 33 and 34, the circuit 20 will begin to oscillate. Assume, for example, that switch 31 is coupled to resistor 34. The value of resistor 34 is selected such that the relaxation oscillator 2t)v will oscillate at a frequency somewhat above zero impulses per second rbut below 30 impulses per second. This is commonly termed as the frequency which will produce twitching of a digital member of a limb of a patient, as for example, a finger or a toe. This will henceforth be defined as the twitching frequency. The exact impulse frequency range to produce twitching will vary with the patient, and therefore af requency of 20 impulses per second is preferred. With switch 31 coupled to the resistor 34, a voltage will be applied to transistor base 23 in such a direction as to cause transistor 21 to turn on. The turning on of transistor 21 causes transistor to turn on. This causes a current to ow within the primary 3S of the transformer 37. Transistors 21 and 25 will continue to conduct as long as the transformer 37 is unsaturated. After a period of time, transformer 37 becomes saturated and a voltage across secondary 39 rapidly reverses according to Lcnzes law. This causes a potential to be applied to base 23 of transistor 21 of such a polarity as to turn off transistor 21. This, in turn, turns off transistor 25. Capacitor which charged in the reverse direction to cut olf transistor 23 due to the saturation of inductor 37 then gradually discharges until the potential at the base electrode 23 of transistor 21 once again becomes of the proper polarity to turn on transistor 21 to restart the cycle.

The resultant output wave form of the oscillator is shown across electrodes 50 and 51. It is to be noted that the topmost portion of the turn on cycle is slightly clipped due to the presence of gas tube 46. This gas tube ckering indicates to the observer that the impulse generating device 20 is operating. Assume now that the switch 31 is coupled to resistor 33. Resistor 33 is selected such that the impulse frequency rate will be in the order of between -120 impulses per second. In the preferred embodiment, 50 impulses per second was chosen. This range of frequencies is generally referred to as the tetanus frequency rate. The tetanus frequency reaction is observed by noticing the involuntary closing of a linger or a toe of a patient. The exact values for the frequency rate for both tetanus and twitching is generally a function of the patient and it is, therefore, to be understood that the ranges described are only illustrative and are not limiting.

Although it is to be understood that many modifications may be made to the above circuit, the following circuit values may be utilized to provide an impulse generating device suitable for generating both tetanus and twitching frequency impulses.

Transistor 21 2N335.

Transistor 25 2Nl66.

Capacitor 30 2O microfarads.

Resistor 33 5.1K ohms.

Resistor 34 330K ohms.

Battery 35 3 volts. Transformer 37 Voltage step-up of approximately 30. Resistor 40 100 ohms.

Capacitor 41 l5 microfarads.

Gas tube 46 NESlH.

The device 20 is capable of providing approximately a 90 R.M.S. output signal across electrodes 50 and 51 when used with a 3-volt battery as the energy source for the circuit. This circuit is particularly usable during the administration of an anesthesia and during operations because it is explosion-proof due to the low value of currents and voltages utilized. To detect the response to the electrical stimuli provided across the electrodes 50 and 51, a digital member such as a finger 53 of arm 52 may be observed. This may be accomplished without the use of any auxiliary detecting and monitoring devices shown in FIG. l. By applying a twitching frequency signal to the electrodes 50 and 51, the twitching signal will produce a periodic contraction of the finger 53. The application of a tetanus signal will draw the finger closed. Thus, the twitching and tetanus signals may be observed by watching the motion of the finger or the toes of a patient.

The use of this information will be described at a later time in this specification in accordance with the method of this invention.

Although the reaction of the patient to the application of tetanus and Ytwitching muscle electrical stimuli mayl be obsterved without the use of electrical equipment, it is preferred that some type of electrical monitoring device be utilized to better assist in the recognition of the patients response.

By the use'of a splint, generally shown at 55, which is suitable for mounting on thumb 53, a device for indicating and displaying the response of the patient may be provided. The splint 55 comprises resilient lat portions 55 and 57 having a bend 58 therebetween. Positioned at one end of resilient member 57 is ring 61 suitable for surrounding the tip portion of patients thumb 53.

Attached to the other member 56 of splint 55 are clamps 62 and 63. These clamps are shaped like rings, but have cut out portions for permitting the clamps to extend over the upper portion of patients thumb 53 above the joint. To record the bending of the splint 55, a suitable strain gage 70 is mounted thereon in a position to record the pressure produced by the thumb against the splint. A strain gage, such as the type SR-4 available from Baldwin-Lima Hamilton Corp., Waltham, Massachusetts, may be used. Other types of strain or stress transducers such as strain sensitive diodes and transistors may also be utilized as well as piezo electric devices. Strain gage 70 is connected to a suitable circuit comprising resistor 72 and battery 73 for providing a current through the strain gage. The variations of the current flow through the strain gage due to a change in resistance of the strain gage because of flexing of thumb 53, can then be monitored on a meter such as a voltage meter or an oscilloscope 75. Further, other display devices may be utilized, for example, electrical type brush recorders.

Referring now to FIGS. 3a, 3b and 3c for a description of the method according to this invention, assume that the patient has been injected with a syringe carry,

ing muscle relaxant drugs such as succinylcholine, or dimethyl tubocurare. Further assume that an anesthesiologist deems it necessary to introduce a muscle antagonistic drug to counteract the effects of the muscle relaxant drug. To determine the proper time to inject the muscle relaxant antagonist is, for example, by the use of a syringe 80 as shown in FIG. l, the neuromuscular block monitoring device 20, is turned on and set to provide electrical stimuli at a twitching frequency. The electrical stimuli is applied at the ulnar nerve at the wrist, elbow or at a motor junction point. It is preferable to use needle electrodes which may be inserted into the arm of the patient, rather than surface electrodes which tend to cause slight damage tothe skin due to irritation of the electrodes after long periods of time as, for example, four hours. FIG. 3a shows the application of the electrical stimuli at a twitching frequency of about twenty impulses per second, although variations may exist due to the particular patient. The response of the patient is shown in FIGS. 3b and 3c and may be observed on the oscilloscope 75. The spikes in FIGS. 3b and 3c indicate that the patient has reacted to the stimuli such as to produce a twitching of the digital member. This can also be observe-d by watching the digital member itself. lAfter a period of time as, for example, 20 seconds monitor oscillating device 20 is then set to provide electrical stimuli at a tetanus frequency. In the preferred embodiment, the monitor is set to provide 50 impulses per seconduwh'ich is shown in FIG. 3a. The application of electrical im'- pulses at tetanus frequency produces a clamping response of the patients hand or toes such that the hand or toes tend to close during the application of the tetanus stimuli. This may be observed by noticing the square wave representation in FIGS. 3b and 3c or, again, by watching the digital member.

In the preferred method, the tetanus is held for approximately two to three seconds although many variations may be possible depending on the response of the patient. To determine the nature of the neuromuscular block, the monitor is switched to provide electrical stimuli at the twitching frequency once again. FIG. 3b shows the response of the patients digit-al members to the re-application of the twitch frequency when there exists a non-depolarizing neuromuscular block within the patient. This figure further shows what is generally termed post-tetanic facilitation and which is represented by a sudden increase in the amplitude of the switch response. This has been determined to vbe the response by the patient to a twitch frequency after ythe application of a tetanus frequency electrical stimuli when there exists a nondepolarizing block within the patient. In FIG. 3c there is shown the response of the patient to the twitch electrical frequency stimuli when there exists a depolarizing neuromuscular block within the patient. In this figure it may be seen that there is no post-tetanic facilitation which is indicative of a depolarizing neuromuscular block.

In accordance with this invention, it has been determined that a muscle antagonist drug should be introduced into the patient only when there exists a nondepolarizing block such as shown by the post-tetanic facilitation of FIG. 3b. The introduction of an antagonist drug when there is a depolarizing block such as shown in FIG. 3c potentiates the depolarizing block rather than counteracting the muscle relaxant drug. If the drug is administered when there is a depolarizing block, the patient generally requires a longer period of time to overcome the relaxant drug then would normally -be required if the neuromuscular block were permitted `to switch from a depolarizing to the non-depolarizing neuromuscular block by itself. This will generally occur after a predetermined time interval h-as elapsed to permit the muscle relaxant 4drum to lose at least some of its potency. It should be understood that a sensor strapped to an arm or leg of the patient could also be utilized although a sensor strapped to a digit-al member is preferred.

It will thus be seen that the objects set forth above, among those made 4apparent from the preceding description, are eiiciently attained and, since certain changes may be made in the above article without departing from the scope of the invention, it is intended that all matter contained in the above description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.

It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention hereindescribed, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.

What we claim is:

1. A method for administering a muscle relaxant antagonist drug to counteract muscle relaxant drugs which produce both non-depolarizing and depolarizing blocks in patients, comprising the steps of first applying an electrical stimulus to the ulnar nerve and/ or the nerve motor point muscle junction of a patient at a switching frequency rate, secondly applying electrical stimulus lat a tetanus frequency rate to the same part of the patient, point muscle junction of a patient at a twitching frequency rate, differentiating between responsiveness of the patient to said stimuli to determine the types of neuromuscular block, and introducing an antagonist into the system of the patient only if the response of the patient is such that a non-depolarizing block exists.

2. A method for the intravenous administration of antagonistic drugs to counteract the effects of drugs producing muscle relaxation, comprising the steps of sequentially applying a low amperage electrical stimuli of two different frequencies to a muscle motor point and/or the ulnar nerve of a patient to produce -a muscle stimulus, and administering the antagonistic drugs only when the response of the patient to the electrical stimuli is such that a non-depolarizing neuromuscular block exists within the patient.

3. A method for Vthe intravenous administration of antagonistic drugs to counteract the effects of muscle relaxant drugs producing 'both depolarizing and nondepolarizing neuromuscular blocks in patients, comprising the steps of sequentially applying an electrical stimulus at both twitching and tetanus frequencies to a muscle motor point and/ or the ulnar nerve of a patient to produce a muscle stimulus, Vand administering antagonistic drugs only when the response of the patient to the electrical stimuli is such that a non-depolarizing neuromuscular block exists.

4. A method for administering muscle relaxation antagonistic drugs to counteract the effects of muscle relaxant drugs which produce both non-depolarizing and depolarizing neuromuscular blocks in patients, comprising the steps of first applying an electrical stimulus at a twitching frequency to the ulnar nerve and/ or the muscle motor point of a, patient, then applying an electrical stimulus at a tetanus frequency to the ulnar nerve and/or the muscle motor point of a patient and then reapplying an electrical stimulus at a twitching frequency to the ulnar nerve and/or the muscle motor point of a patient, and administering antagonistic drugs only when the response of the patient is such that a depol-arizing neuromuscular `block will not be potentiated.

References Cited UNITED STATES PATENTS 2,493,155 1/1950 McMillan 128-172.1 2,808,826 10/1957 Reiner et al 12S-2.1 2,830,578 4/1958 De Groff 12S- 24.5 2,840,069 6/ 1958 Squire et al. 12S-2 3,200,814 8/1965 Taylor et al. 12S-2 3,207,151 9/ 1965 Takagi 12S-2.1 3,258,007 6/1966 Karpovich et a1. 12S-2 3,292,620 12/ 1966 Mahler 12S-172.1 2,979,055 4/ 1961 De Beer et al 12S-214 RICHARD A. GAUDET, Primary Examiner. SIMON BRODER, Examiner,

Disclaimer 3,364,929. Walter S. lele, Eastchesber, and William H. Nickerson, Tuckahoe, N.Y. METHOD FOR ADMIN ISTERING MUSCLE RELAXANT DRUG. Patent dated J an. 23, 1968. Disclaimer filed Apr. 20, 197 8, by the assignee, Burroughs Wellcome 00. Hereby enters this disclaimer to all claims of said patent.

[Oficial Gazette June 13, 1.978.]

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2493155 *Jan 9, 1947Jan 3, 1950Mine Safety Appliances CoApparatus for treating skin diseases
US2808826 *Jan 19, 1956Oct 8, 1957Teca CorpElectro-diagnostic apparatus and a circuit therefor
US2830578 *Jan 31, 1957Apr 15, 1958Mark E DegroffElectro-sonic apparatus
US2840069 *Sep 22, 1955Jun 24, 1958Nat Res DevPenetrating instruments such as hypodermic needles and their use in an imbibition pressure meter
US2979055 *Jun 18, 1954Apr 11, 1961Burroughs Wellcome CoMethod for the administration of muscle relaxant drugs
US3200814 *Mar 12, 1963Aug 17, 1965Richard F ChandlerApparatus for measuring reflexes, tremors and the like
US3207151 *Sep 17, 1962Sep 21, 1965Tateisi Denki KabushikikaishaInstrument for locating particular cutaneous points caused by viscerovascular reflex
US3258007 *Jul 19, 1963Jun 28, 1966Peter V KarpovichRotary electrogoniometer for measuring degree of rotation of the forearm
US3292620 *Jul 30, 1963Dec 20, 1966Instro Dynamics CorpElectric desensitizer
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3468302 *May 20, 1966Sep 23, 1969Godfrey BrookeSkin resistance reaction time testing apparatus
US3513834 *Nov 21, 1967May 26, 1970Hitachi LtdAnesthetic depth measuring system
US3570473 *Feb 28, 1966Mar 16, 1971Cargille Scient IncManually controllable medical aid oscillator instrument
US3618601 *Oct 16, 1969Nov 9, 1971Richardson Thatcher WIontophoresis unit
US3898983 *Oct 3, 1973Aug 12, 1975James O ElamDevice and method for detecting the degree of muscle relaxation of a medical patient
US3908669 *Dec 17, 1973Sep 30, 1975American Acupuncture Medical IApparatus for use by physicians in acupuncture research
US4291705 *Sep 10, 1979Sep 29, 1981The Regents Of The University Of CaliforniaNeuromuscular block monitor
US4387723 *Dec 9, 1980Jun 14, 1983Wisconsin Alumni Research FoundationMethod and apparatus for determining the level of neuromuscular block in a patient
US4399821 *Feb 19, 1981Aug 23, 1983Bowers David LFree moving animal physiological monitoring and identification system and method
US4411268 *Feb 10, 1982Oct 25, 1983Medtronic, Inc.Muscle stimulator
US4558704 *Dec 15, 1983Dec 17, 1985Wright State UniversityFor a quadriplegic person
US4595018 *Jun 6, 1984Jun 17, 1986Instrumentarium Corp.Method of further developing the measuring of a neuro-muscular junction
US4644959 *Nov 1, 1984Feb 24, 1987Sergiu CalmanoviciMethod of functional assessment of cancer humoral factors
US4748987 *Sep 25, 1985Jun 7, 1988The University Of MichiganMethod of determining muscle fatigue
US4795433 *Mar 31, 1988Jan 3, 1989Survival Technology, Inc.Automatic injector for emergency treatment
US4807643 *Aug 16, 1982Feb 28, 1989University Of Iowa Research FoundationDetermining motor/sensory peripheral nerve potentials
US4817628 *Oct 18, 1985Apr 4, 1989David L. ZealearSystem and method for evaluating neurological function controlling muscular movements
US4832682 *May 20, 1985May 23, 1989Survival Technology, Inc.Injection method and apparatus with electrical blood absorbing stimulation
US4962766 *Jul 19, 1989Oct 16, 1990Herzon Garrett DNerve locator and stimulator
US4986280 *Jul 20, 1988Jan 22, 1991Arthur D. Little, Inc.Hand position/measurement control system
US5020542 *Apr 16, 1990Jun 4, 1991Charles RossmannMethod of measuring skin sensitivity to electrical stimulation
US5085226 *May 30, 1990Feb 4, 1992Trustees Of Boston UniversityForce monitoring apparatus for back muscles
US5284153 *Apr 14, 1992Feb 8, 1994Brigham And Women's HospitalMethod for locating a nerve and for protecting nerves from injury during surgery
US5284154 *Oct 23, 1992Feb 8, 1994Brigham And Women's HospitalApparatus for locating a nerve and for protecting nerves from injury during surgery
US5775331 *Jun 7, 1995Jul 7, 1998Uromed CorporationApparatus and method for locating a nerve
US6226552 *Apr 16, 1999May 1, 2001Stryker InstrumentsNeuromuscular electrical stimulation for preventing deep vein thrombosis
US6312392Apr 6, 2000Nov 6, 2001Garrett D. HerzonBipolar handheld nerve locator and evaluator
US6466817Jun 8, 2000Oct 15, 2002Nuvasive, Inc.Nerve proximity and status detection system and method
US6500128Jun 8, 2001Dec 31, 2002Nuvasive, Inc.Nerve movement and status detection system and method
US6564078Jun 4, 1999May 13, 2003Nuvasive, Inc.Nerve surveillance cannula systems
US7058438 *Apr 1, 2003Jun 6, 2006Grace Lawrence JMethod and apparatus for self-diagnostic evaluation of nerve sensory latency
US7079883May 7, 2003Jul 18, 2006Nuvaslve, Inc.Nerve surveillance cannulae systems
US7177677Oct 16, 2002Feb 13, 2007Nuvasive, Inc.Nerve proximity and status detection system and method
US7207949May 25, 2005Apr 24, 2007Nuvasive, Inc.Surgical access system and related methods
US7470236Nov 24, 2000Dec 30, 2008Nuvasive, Inc.Electromyography system
US7522953Mar 25, 2004Apr 21, 2009Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US7582058Jun 26, 2003Sep 1, 2009Nuvasive, Inc.Surgical access system and related methods
US7643884Jan 31, 2005Jan 5, 2010Warsaw Orthopedic, Inc.Electrically insulated surgical needle assembly
US7657308Feb 18, 2005Feb 2, 2010Nuvasive, Inc.System and methods for performing dynamic pedicle integrity assessments
US7664544Apr 30, 2004Feb 16, 2010Nuvasive, Inc.System and methods for performing percutaneous pedicle integrity assessments
US7691057Jan 16, 2004Apr 6, 2010Nuvasive, Inc.Surgical access system and related methods
US7693562Oct 31, 2007Apr 6, 2010Nuvasive, Inc.Nerve surveillance cannulae systems
US7785253Jan 31, 2006Aug 31, 2010Nuvasive, Inc.Surgical access system and related methods
US7819801Feb 27, 2004Oct 26, 2010Nuvasive, Inc.Surgical access system and related methods
US7892173Dec 7, 2009Feb 22, 2011Nuvasive, Inc.Surgical access system and related methods
US7905840Oct 18, 2004Mar 15, 2011Nuvasive, Inc.Surgical access system and related methods
US7920922Feb 24, 2010Apr 5, 2011Nuvasive, Inc.System and methods for determining nerve proximity, direction, and pathology during surgery
US7935051Apr 22, 2009May 3, 2011Nuvasive, Inc.Surgical access system and related methods
US7962191Oct 31, 2007Jun 14, 2011Nuvasive, Inc.Nerve surveillance cannulae systems
US7963927Apr 21, 2004Jun 21, 2011Nuvasive, Inc.Electromyography system
US8000782Dec 1, 2009Aug 16, 2011Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8005535Apr 14, 2009Aug 23, 2011Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8016767Apr 23, 2007Sep 13, 2011Nuvasive, Inc.Surgical access system and related methods
US8027716Apr 20, 2009Sep 27, 2011Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8050769May 1, 2009Nov 1, 2011Nuvasive, Inc.System and methods for determining nerve proximity, direction, and pathology during surgery
US8068912Jan 9, 2004Nov 29, 2011Nuvasive, Inc.System and methods for determining nerve proximity, direction, and pathology during surgery
US8090436Oct 29, 2009Jan 3, 2012Nuvasive, Inc.Tissue discrimination and applications in medical procedures
US8092455Feb 7, 2005Jan 10, 2012Warsaw Orthopedic, Inc.Device and method for operating a tool relative to bone tissue and detecting neural elements
US8114019Dec 30, 2009Feb 14, 2012Nuvasive, Inc.Surgical access system and related methods
US8133173Dec 30, 2009Mar 13, 2012Nuvasive, Inc.Surgical access system and related methods
US8137284Oct 8, 2003Mar 20, 2012Nuvasive, Inc.Surgical access system and related methods
US8147421Jul 15, 2005Apr 3, 2012Nuvasive, Inc.System and methods for determining nerve direction to a surgical instrument
US8165653Jun 14, 2011Apr 24, 2012Nuvasive, Inc.Surgical access and nerve surveillance
US8172750Mar 17, 2010May 8, 2012Nuvasive, Inc.Surgical access system and related methods
US8182423Dec 30, 2009May 22, 2012Nuvasive, Inc.Surgical access system and related methods
US8187179Dec 30, 2009May 29, 2012Nuvasive, Inc.Surgical access system and related methods
US8192356Dec 10, 2009Jun 5, 2012Nuvasive, Inc.Surgical access system and related methods
US8192357Dec 30, 2009Jun 5, 2012Nuvasive, Inc.Surgical access system and related methods
US8206312Sep 22, 2006Jun 26, 2012Nuvasive, Inc.Multi-channel stimulation threshold detection algorithm for use in neurophysiology monitoring
US8244343Aug 23, 2011Aug 14, 2012Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8255044Feb 2, 2010Aug 28, 2012Nuvasive, Inc.System and methods for performing dynamic pedicle integrity assessments
US8255045 *Apr 3, 2008Aug 28, 2012Nuvasive, Inc.Neurophysiologic monitoring system
US8265744Aug 16, 2011Sep 11, 2012Nuvasive, Inc.Systems and methods for performing surgical procedures and assessments
US8287597Apr 16, 2010Oct 16, 2012Nuvasive, Inc.Method and apparatus for performing spine surgery
US8303498Feb 18, 2011Nov 6, 2012Nuvasive, Inc.Surgical access system and related methods
US8303515Dec 11, 2009Nov 6, 2012Nuvasive, Inc.Surgical access system and related methods
US8313430Jan 11, 2007Nov 20, 2012Nuvasive, Inc.Surgical access system and related methods
US8328851Jul 28, 2006Dec 11, 2012Nuvasive, Inc.Total disc replacement system and related methods
US8343046Mar 12, 2012Jan 1, 2013Nuvasive, Inc.Surgical access system and related methods
US8355780Nov 20, 2009Jan 15, 2013Nuvasive, Inc.Surgical access system and related methods
US8388527Dec 31, 2009Mar 5, 2013Nuvasive, Inc.Surgical access system and related method
US8403841Dec 14, 2009Mar 26, 2013Nuvasive, Inc.Surgical access system and related methods
US8425430Dec 10, 2009Apr 23, 2013Warsaw Orthopedic, Inc.Electrically insulated surgical needle assembly
US8439832Jan 4, 2011May 14, 2013Nuvasive, Inc.Surgical access system and related methods
US8500634Jan 17, 2013Aug 6, 2013Nuvasive, Inc.Surgical access system and related methods
US8500653Jun 26, 2012Aug 6, 2013Nuvasive, Inc.Neurophysiology monitoring system configured for rapid stimulation threshold acquisition
US8512235Jun 1, 2012Aug 20, 2013Nuvasive, Inc.Surgical access system and related methods
US8523768May 8, 2012Sep 3, 2013Nuvasive, Inc.Surgical access system and related methods
US8548579Aug 7, 2012Oct 1, 2013Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8550994Nov 5, 2012Oct 8, 2013Nuvasive, Inc.Surgical access system and related methods
US8556808Jan 15, 2013Oct 15, 2013Nuvasive, Inc.Surgical access system and related methods
US8562521Feb 1, 2013Oct 22, 2013Nuvasive, Inc.Surgical access system and related methods
US8562539Aug 21, 2007Oct 22, 2013Nuvasive, Inc.Electromyography system
US8568317Sep 27, 2006Oct 29, 2013Nuvasive, Inc.System and methods for nerve monitoring
US8568331Feb 2, 2006Oct 29, 2013Nuvasive, Inc.System and methods for monitoring during anterior surgery
US8591432Jan 3, 2011Nov 26, 2013Nuvasive, Inc.Surgical access system and related methods
US8602982Apr 4, 2013Dec 10, 2013Nuvasive, Inc.Surgical access system and related methods
US8628469Jul 30, 2013Jan 14, 2014Nuvasive, Inc.Surgical access system and related methods
US8634904Nov 8, 2011Jan 21, 2014Nuvasive, Inc.System and methods for determining nerve proximity, direction, and pathology during surgery
US8652140Jan 3, 2012Feb 18, 2014Warsaw Orthopedic, Inc.Device and method for operating a tool relative to bone tissue and detecting neural elements
US8663100Sep 4, 2013Mar 4, 2014Nuvasive, Inc.Surgical access system and related methods
US8672840May 8, 2012Mar 18, 2014Nuvasive, Inc.Surgical access system and related methods
US8679006Feb 1, 2013Mar 25, 2014Nuvasive, Inc.Surgical access system and related methods
US8696559Feb 1, 2013Apr 15, 2014Nuvasive, Inc.Surgical access system and related methods
US8708899Feb 1, 2013Apr 29, 2014Nuvasive, Inc.Surgical access system and related methods
US8738123Feb 11, 2013May 27, 2014Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8740783Jul 20, 2006Jun 3, 2014Nuvasive, Inc.System and methods for performing neurophysiologic assessments with pressure monitoring
US8747307Sep 4, 2013Jun 10, 2014Nuvasive, Inc.Surgical access system and related methods
US8753270Jul 31, 2013Jun 17, 2014Nuvasive, Inc.Surgical access system and related methods
US8753271Jan 13, 2014Jun 17, 2014Nuvasive, Inc.Surgical access system and related methods
US8764649Oct 11, 2013Jul 1, 2014Nuvasive, Inc.Surgical access system and related methods
US8768450Feb 8, 2013Jul 1, 2014Nuvasive, Inc.System and methods for performing surgical procedures and assessments
US8790406Apr 2, 2012Jul 29, 2014William D. SmithSystems and methods for performing spine surgery
US8812116May 7, 2012Aug 19, 2014Nuvasive, Inc.System and methods for determining nerve proximity, direction, and pathology during surgery
US8821396Jun 9, 2014Sep 2, 2014Nuvasive, Inc.Surgical access system and related methods
US8827900Nov 20, 2012Sep 9, 2014Nuvasive, Inc.Surgical access system and related methods
US8870960Dec 11, 2012Oct 28, 2014Nuvasive, Inc.Total disc replacement system and related methods
US8915846Apr 18, 2013Dec 23, 2014Nuvasive, Inc.Surgical access system and related methods
US8920500Oct 16, 2012Dec 30, 2014Nuvasive, Inc.Methods and apparatus for performing spine surgery
US8942801Jun 9, 2014Jan 27, 2015Nuvasive, Inc.Surgical access system and related methods
US8945004Aug 1, 2014Feb 3, 2015Nuvasive, Inc.Surgical access system and related methods
USRE44049 *Nov 6, 2003Mar 5, 2013Garrett D. HerzonBipolar handheld nerve locator and evaluator
EP0025222A2 *Sep 4, 1980Mar 18, 1981The Regents Of The University Of CaliforniaApparatus for monitoring neuromuscular transmission
WO1986006965A1 *May 19, 1986Dec 4, 1986Survival TechnologyInjection method and apparatus with electrical blood absorbing stimulation
WO1999053996A1 *Apr 16, 1999Oct 28, 1999Stryker InstrNeuromuscular electrical stimulation for preventing deep vein thrombosis
Classifications
U.S. Classification600/554, 331/111, 607/48, 600/595, 607/74, 600/546
International ClassificationA61N1/34, A61N1/36, A61B5/11, A61B5/05
Cooperative ClassificationA61B5/05, A61N1/36021, A61B5/1106
European ClassificationA61N1/36E, A61N1/36E4, A61N1/36E2, A61N1/36, A61B5/05, A61B5/11H4